BIOFRONTERA ($BFRI) Releases Q2 2026 Earnings
Biofrontera Inc (BFRI) reported strong Q2 2026 results, driven by significant Ameluz growth and successful commercial expansion, leading to increased revenue and improved gross margins. Despite heightened operating expenses and competition, the company maintains a solid cash position and projects 30-35% revenue growth for …